12.56
Clearpoint Neuro Inc stock is traded at $12.56, with a volume of 200.20K.
It is down -4.70% in the last 24 hours and down -31.66% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$13.18
Open:
$13.16
24h Volume:
200.20K
Relative Volume:
0.82
Market Cap:
$347.06M
Revenue:
$30.43M
Net Income/Loss:
$-18.15M
P/E Ratio:
-18.20
EPS:
-0.69
Net Cash Flow:
$-9.08M
1W Performance:
-4.78%
1M Performance:
-31.66%
6M Performance:
-0.24%
1Y Performance:
+75.17%
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CLPT
Clearpoint Neuro Inc
|
12.56 | 347.06M | 30.43M | -18.15M | -9.08M | -0.69 |
![]()
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-25-24 | Resumed | B. Riley Securities | Buy |
Oct-24-23 | Initiated | Stifel | Buy |
Feb-16-23 | Resumed | B. Riley Securities | Buy |
Apr-05-22 | Resumed | B. Riley Securities | Buy |
Mar-18-21 | Initiated | Lake Street | Buy |
Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Tuesday - Defense World
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results - ACCESS Newswire
How To Trade (CLPT) - Stock Traders Daily
What is B. Riley’s Forecast for CLPT FY2025 Earnings? - Defense World
Taylor Frigon Capital Management LLC Sells 162,551 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
ClearPoint Neuro’s Earnings Call Highlights Robust Growth - TipRanks
MRI Interventions, Inc. Announces 2016 Third Quarter and Nine Month Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Issues Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates - MSN
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2024 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro Achieves Record Growth in 2024 - TipRanks
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: ClearPoint Neuro Q4 2024 sees stock dip post-earnings - Investing.com India
ClearPoint Neuro Reports Record 2024 Revenue Growth - TipRanks
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results - ACCESS Newswire
ClearPoint Neuro Crushes Expectations With 76% Product Revenue Surge in Latest Earnings - StockTitan
ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Clearpoint Neuro Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday - Defense World
(CLPT) Trading Report - Stock Traders Daily
The Power Shift: How Small Investors Rule ClearPoint Neuro - Elblog.pl
Power to the People: How Individual Investors Are Influencing ClearPoint Neuro - Zaman
While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 22.1% in January - MarketBeat
Solventum (NYSE:SOLV) and ClearPoint Neuro (NASDAQ:CLPT) Head-To-Head Review - Defense World
What Do Wall Street Analysts Think About ClearPoint Neuro Inc (NASDAQ: CLPT) Stock? - Stocks Register
Legato Capital Management LLC Lowers Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 25% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 - ACCESS Newswire
ClearPoint Neuro Sets Stage for Crucial 2024 Financial Review: What the Brain Tech Leader Will Reveal - StockTitan
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula - WICZ
Game-Changing Brain Drug Delivery Device Gets Major EU Regulatory Win - StockTitan
ClearPoint Neuro (NASDAQ:CLPT) Hits New 12-Month HighTime to Buy? - MarketBeat
CLS publishes half-year report JanuaryJune 2024 - Finansavisen
(CLPT) Investment Report - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) Shares Up 8.5%Time to Buy? - MarketBeat
JPMorgan Chase & Co. Has $110,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
B. Riley Boosts ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - MarketBeat
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
B. Riley Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - Defense World
How to Take Advantage of moves in (CLPT) - Stock Traders Daily
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target By Investing.com - Investing.com UK
ClearPoint Neuro price target raised to $20 from $15 at B. Riley - Yahoo Finance
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):